← All organizations

NightstaRx Limited

For profitWebsite ↗

Also known as: Nightstar Therapeutics

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2017

Last known activity

Dec 11, 2017

Acquired by Biogen-IDEC on Mar 4, 2019

Timeline

2010s

  1. Jun 1, 2017

    NightstaRx Limited— Founded

  2. Mar 4, 2019

    Biogen-IDEC— Acquired By

Drugs by trial phase (2 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Indications

Recent trials (4)

Details

Founded
London, GB Jun 1, 2017
Last known activity
Dec 11, 2017